This study aims to examine the potential effects and mechanisms of Corilagin on atherosclerosis through the Olfr2 pathway, employing treatments on Ana-1 cells, primary mouse bone marrow-derived macrophages (BMDMs), and atherosclerotic models in ApoE−/− mice. The gene discussed is OR2H2; the disease is atherosclerosis.